2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide

C55H68N8O8S — CID 175757140

IUPAC2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide
SMILESCOC1(C)CCC(CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCC5(CC4)CC(N4CCC[C@H]4c4ccccc4C(C)C)C5)cc3N3C[C@H]4COC[C@@H]4Oc4nc5[nH]ccc5cc43)cc2[N+](=O)[O-])CC1
InChIInChI=1S/C55H68N8O8S/c1-35(2)42-8-5-6-9-43(42)46-10-7-23-61(46)40-29-55(30-40)20-24-60(25-21-55)39-11-13-44(47(27-39)62-32-38-33-70-34-50(38)71-53-49(62)26-37-17-22-56-51(37)58-53)52(64)59-72(67,68)41-12-14-45(48(28-41)63(65)66)57-31-36-15-18-54(3,69-4)19-16-36/h5-6,8-9,11-14,17,22,26-28,35-36,38,40,46,50,57H,7,10,15-16,18-21,23-25,29-34H2,1-4H3,(H,56,58)(H,59,64)/t36?,38-,46-,50-,54?/m0/s1
InChIKeyPFMBGDSEFDSJLN-YEAMFRLNSA-N
MW1001.26 g/mol
LogP9.85
Rot. Bonds13

About 2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide

2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide (PubChem CID 175757140) has the molecular formula C55H68N8O8S and a molecular weight of 1001.26 g/mol. Its IUPAC name is 2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide.

Molecular Properties

Compound Name2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide
PubChem CID175757140
Molecular FormulaC55H68N8O8S
Molecular Weight1001.26 g/mol
Exact Mass1000.49
IUPAC Name2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide
SMILESCOC1(C)CCC(CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCC5(CC4)CC(N4CCC[C@H]4c4ccccc4C(C)C)C5)cc3N3C[C@H]4COC[C@@H]4Oc4nc5[nH]ccc5cc43)cc2[N+](=O)[O-])CC1
InChIInChI=1S/C55H68N8O8S/c1-35(2)42-8-5-6-9-43(42)46-10-7-23-61(46)40-29-55(30-40)20-24-60(25-21-55)39-11-13-44(47(27-39)62-32-38-33-70-34-50(38)71-53-49(62)26-37-17-22-56-51(37)58-53)52(64)59-72(67,68)41-12-14-45(48(28-41)63(65)66)57-31-36-15-18-54(3,69-4)19-16-36/h5-6,8-9,11-14,17,22,26-28,35-36,38,40,46,50,57H,7,10,15-16,18-21,23-25,29-34H2,1-4H3,(H,56,58)(H,59,64)/t36?,38-,46-,50-,54?/m0/s1
InChIKeyPFMBGDSEFDSJLN-YEAMFRLNSA-N
XLogP9.85
TPSA184.50 Ų
H-Bond Donors3
H-Bond Acceptors13
Rotatable Bonds13
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001001.26
LogP ≤ 59.85
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide?
The IUPAC name of 2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide (CID 175757140) is 2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide.
What is the SMILES notation for 2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide?
The canonical SMILES for 2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide is COC1(C)CCC(CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCC5(CC4)CC(N4CCC[C@H]4c4ccccc4C(C)C)C5)cc3N3C[C@H]4COC[C@@H]4Oc4nc5[nH]ccc5cc43)cc2[N+](=O)[O-])CC1.
What is the InChIKey of 2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide?
The InChIKey is PFMBGDSEFDSJLN-YEAMFRLNSA-N. The full InChI is InChI=1S/C55H68N8O8S/c1-35(2)42-8-5-6-9-43(42)46-10-7-23-61(46)40-29-55(30-40)20-24-60(25-21-55)39-11-13-44(47(27-39)62-32-38-33-70-34-50(38)71-53-49(62)26-37-17-22-56-51(37)58-53)52(64)59-72(67,68)41-12-14-45(48(28-41)63(65)66)57-31-36-15-18-54(3,69-4)19-16-36/h5-6,8-9,11-14,17,22,26-28,35-36,38,40,46,50,57H,7,10,15-16,18-21,23-25,29-34H2,1-4H3,(H,56,58)(H,59,64)/t36?,38-,46-,50-,54?/m0/s1.
What are the key properties of 2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide?
2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide has a molecular weight of 1001.26 g/mol, XLogP of 9.85, 13 rotatable bonds, 3 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(3R,7S)-2,5-dioxa-9,15,17-triazatetracyclo[8.7.0.03,7.012,16]heptadeca-1(10),11,13,16-tetraen-9-yl]-N-[4-[(4-methoxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]benzamide is sourced from PubChem (CID 175757140), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).